Monday-Friday 6:00am – 5:00pm | Saturday 6:00am – 12:00pm
CorePlus and Ibex show real world success with AI for routine cancer diagnosis
January 5, 2024CorePlus and Ibex show real world success with AI for routine cancer diagnosis.ArteraAI Announces Research Agreement with CorePlus
January 5, 2024ArteraAI, a developer of AI-based cancer tests, has partnered with CorePlus, a CLIA-certified pathology laboratory in Puerto Rico.CorePlus partners with Alpenglow Biosciences and positions itself as a leader in the new era of 3D pathology
October 11, 2023The innovation will enable pathologists to improve accuracy in diagnosing prostate cancer.